Back

Use of anti-arrhythmic drug therapy in patients treated with Cryoballoon pulmonary vein isolation for paroxysmal atrial fibrillation: data from a multicenter observational project

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial fibrillation ablation - Cryoballoon Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Maurizio Landolina

Maggiore Hospital of Crema, Crema (Italy)

10 More presentations in this session

Presentation thumbnail
Pulmonary vein (PV) cryo-balloon ablation achieves ideal anatomical PV isolation as detected by Cardiac Magnetic Resonance imaging: a proof of concept study
Doctor M. Rav Acha (Jerusalem, IL)
Abstract
Presentation thumbnail
Second generation cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation: outcomes beyond one-year follow-up time
Doctor V. Galizia Brito (Palma de Mallorca, ES)
Abstract
Presentation thumbnail
The intracardiac speckle-tracking echocardiography as a method of the cryoablation efficacy assessment in patients with the atrial fibrillation
Mr A. Smorgon (Tomsk, RU)
Abstract Slides
Presentation thumbnail
Mechanism of atrial tachycardia following atrial fibrillation ablation using the second generation cryoballoon
Mr E. Lian (Kiel, DE)
Abstract
Presentation thumbnail
Cryoballoon-PVI is safe and efficacious in overweight patients
Doctor N. Deubner (Nuremberg, DE)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Atrial fibrillation ablation - Cryoballoon

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources